Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • “MONOCAPRIN”—NATURAL EYE-DROP TO ERADICATE BLINDNESS IN INFANTS

KSCSTE Post Doctoral Fellowship 2020 | Applications Invited

AMNIOTIC BAND SYNDROME

“MONOCAPRIN”—NATURAL EYE-DROP TO ERADICATE BLINDNESS IN INFANTS
  • BiotechToday
  • World

“MONOCAPRIN”—NATURAL EYE-DROP TO ERADICATE BLINDNESS IN INFANTS

bioxone October 12, 2020October 11, 2020

RUCHITA KARMAKAR, AMITY UNIVERSITY KOLKATA

Researchers from Kingston University have found out an effective, natural eye drop for the infants who are subjected to a bacterial infection that causes blindness, without causing any kind of irritation. ‘Gonorrhoea’ which is a sexually transmitted disease (STD) caused by the bacteria “Neisseria gonorrhoeae” is resistant to the antibiotics used to nurse it. This contamination can be passed down from a pregnant mother to the baby and infect the eye if it not treated at the right time can ultimately lead to permanent blindness.

The research team from Kingston University has been surveying the prospective of the antimicrobial agent ‘monocaprin’ standing as an alternative measure to the treatment against gonorrhoea infections. The researchers trust that it has the probability to both eradicate the growing threat of the antibiotic resistance and also an easy-to-produce medication in the different parts of the world where accessing treatment is harder.

What is MONOCAPRIN?

It is a ‘monoglyceride’, which is indeed a modified fatty acid and the research team noted that it has the potentiality to kill ‘Neisseria gonorrhoeae’. The major journal Scientific Reports by Nature Research, the team has shown how it can be managed in an eye-drop without causing any irritation. The preparation was so far examined on bovine eyes obtained from abattoirs; the next step is to go for the human trials. Researchers are searching for natural agents which are high in monocaprin. 

Thus, monocaprin eye-drop stands as proof of how materials extracted from nature are useful to combat different critical conditions.

Also read: Coronavirus | Government to map out cold storage facilities for COVID-19 vaccine delivery

Citation: Churchward, C.O., et al. (2020) Monocaprin eye drop formulation to combat antibiotic-resistant gonococcal blindness.

Site: https://www.news-medical.net/news/20201009/Natural-eye-drop-could-help-fight-antibiotic-resistant-gonococcal-blindness-in-infants.aspx

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged antibiotic-resistant bacterial infection bovine eyes eye-drop Gonorrhoea Kingston university monocaprin monoglyceride Neisseria gonorrhoeae pregnant mother sexually transmitted disease

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Biotechnopedia
  • DNA-Tales

AMNIOTIC BAND SYNDROME

bioxone October 12, 2020

Pragya Raj, Amity University Kolkata  Amniotic Band Syndrome (ABS) is the congenital malformations related to the amniotic bands which entangle the fetal parts during the pregnancy term, results in a wide range of anatomical disturbances like constriction rings, bizarre multiple congenital anomalies. ABS occurs rarely but should be considered with a newborn with congenital anomalies. […]

AMNIOTIC BAND SYNDROME

Related Post

  • BiotechToday
  • World

Chronoculture: Plant-based biological clock

bioxone May 14, 2021May 14, 2021

Arka Acharyya, Ramakrishna Mission Vivekananda Centenary College, Rahara We live on a rotating planet and that has an immense impact on Chronobiology. Like humans and other animals, plants also have an ‘internal clock’ that controls the daily and seasonal rhythms. According to the plant scientists of Cambridge University, the genetic architecture of circadian oscillators should […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Gene therapy clinical trials for rare Angelman syndrome put on hold

bioxone November 7, 2020November 6, 2020

Surupa Chakraborty, Amity University Kolkata A new gene therapy clinical trial for treating Angelman syndrome has been put to hold after two candidates temporarily lost their ability to walk. GTX102, the drug used in the clinical trial was developed by a California-based biopharmaceutical company Ultragenyx, in collaboration with GeneTx, a Florida-based biotech startup. The trial […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Intravenous Tocilizumab Therapy can tackle Cytokine Storm in COVID-19 patients

bioxone October 24, 2020October 24, 2020

Chitra Roy, University of Calcutta Since its emergence, COVID-19 has been constantly challenging the medical health system across the globe. COVID-19 infection is primarily accompanied by the aggressive inflammatory response with the release of excessive amounts of pro-inflammatory cytokines which are called ‘Cytokine Storm’. The immune response of the host to SARS-CoV-2 virus is extremely […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy